Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Victory
Victory Capital reports Total Client Assets of $360.2 billion as of Aug. 31, 2026.

August total client assets increased to $360.2 billion from $348.8 billion a month earlier, while AUM stood at $356.5 billion. This marks a significan...

HWH
Direct wholly-owned subsidiary acquisition

HWH International implemented an acquisition of Hearty Nova for nominal consideration to indirectly control a Nigeria-Nickel liquefaction project....

New
New Fortress Energy files amended restated certificate of incorporation

New Fortress Energy Inc. filed an Amended and Restated Certificate of Incorporation with the Delaware Secretary of State, effective on the filing date...

AtaiBeckley
AtaiBeckley Files Exhibits

AtaiBeckley filed an amended certificate of incorporation with the SEC, detailing its corporate structure and authorized shares. The restructuring aff...

Aon
EY approves incorporation of report

Aon's auditors consented to incorporating their report for certain S-3 and S-8 filings, ensuring regulatory compliance on past financial statements....

Apimeds
Apimeds amends settlement agreement for board structure

Apimeds Pharmaceuticals US Inc. filed a first amendment to a confidential settlement agreement, removing a specific Board of Directors composition tim...

FIRST
FREIT reports Q3 FY2026 GAAP EPS of $2.69 driven by sale of Franklin Crossing

FREIT reported record GAAP earnings per share of $2.69 for the fiscal quarter ended July 31, 2026, fueled by a net gain on the sale of the Franklin Cr...

COFFEE
Coffee Holding Reports Q3 Net Sales Decrease Amid Market Volatility

Coffee Holding Company reported reduced net sales and higher income for Q3, attributing performance to favorable inventories, tariff refunds, and net ...

BUTLER
Butler National Corp Q1 2027 Revenue Increases 53%

Butler National Corp reported fiscal 2027 first-quarter revenue of $30.8 million, a 53% increase year-over-year. The company also achieved a 24% opera...

Cardlytics,
Cardlytics settles legal dispute with former director Amit Jain

Cardlytics, Inc. has reached a settlement agreement with Amit Jain to resolve claims regarding the advancement of legal expenses related to the DailyG...

Hudson
Hudson Pacific Extends $1.1B Loan to Nov 2027

Hudson Pacific extended a $1.1 billion CMBS loan with no principal paydown, removing near-term maturity risk while reallocating funds to a leasing res...

bioAffinity
Company adjusts outlook for 2024 market performance.

bioAffinity Technologies downgrades its guidance for 2024 due to market dynamics, focusing on strategic priorities....

BOSTON
Boston Omaha Board Authorizes $30 Million Share Buyback

Boston Omaha authorized a new $30 million share repurchase program to replace the prior expiring plan, signaling the company's strategy to return capi...

Alcoa
South32 to propose sale of aluminum assets to Alcoa for $6.6 billion

South32 triggered a special general meeting to vote on the sale of its aluminum value chain to Alcoa. The Directors recommend Shareholders vote in fav...

Rent
Backstop Purchasers agree to fund Rights Offering

Rent the Runway secured agreements from CHS, Nexus, and Story3 to purchase shares, ensuring the company receives $15 million in capital....

Jerash
Jerash Holdings Reports Certifying Stockholder Vote Results

Jerash Holdings announced the election of five directors and shareholder approval of executive compensation during the 2026 annual meeting. The outcom...

HPS
HPS Corporate Lending Fund reports share repurchases and portfolio performance

HPS Corporate Lending Fund authorized a $600 million share repurchase for the third quarter of 2026 and reported strong portfolio growth and profitabi...

Gossamer
Gossamer Bio amends charter to add reverse split

On July 14, 2026, stockholders approved an amendment to amend the capitalization of the Corporation by authorizing shares exchange for a 1-for-80 reve...

Columbus
Columbus Acquisition Adjourns Stockholder Meeting

Columbus Acquisition Corp adjourned its stockholder meeting without conducting business to approve a proposed business combination. The company will p...

Opus
Opus Genetics reports OPGx-BEST1 Phase 1/2 results

Opus Genetics announced 3-month results from the low dose cohort of its OPGx-BEST1 study, a gene therapy for BEST1-related retinal disease. The ongoin...